opioids

Unique Opportunity to Personalize Deep Brain Stimulation for Severe Opioid Use Disorder Yields Highly Specific Target & Clinical Remission in a Patient
Researchers co-led by BBRF grantees have conducted a clinical test of a new way to target deep-brain stimulation (DBS)-based treatments to prevent drug craving and relapse in a patient with… Read More
A Strategy to Sharply Blunt Addictive Reward From Opioids While Retaining Their Pain-Relieving Properties
Since the 1990s, deaths due to opioid overdoses have become a leading cause of death for Americans under age 50. While a portion of these deaths are due to recreational use of opioids, many others… Read More
Machine Learning Is Harnessed To Predict Risk of Opioid Use Disorder
Opioid overdose has become a public health problem of the first magnitude, identified as the cause of death in over 80,000 cases in the U.S. in 2021—about three-fourths of total deaths attributed to… Read More
Large Genome Study Finds a ‘General Addiction Risk Factor’ Commonly Inherited Across Multiple Substance-Use Disorders
In recent years, studies involving large numbers of individuals have identified numerous locations in the human genome where commonly occurring variations in DNA sequence are associated with… Read More
Combining the Antipsychotic Olanzapine with an Opioid-Receptor Blocker Significantly Limited Weight-Gain Risk in Schizophrenia Patients
A clinical trial involving over 500 adults diagnosed with schizophrenia has found that by adding the drug samidorphan to the antipsychotic medicine olanzapine, it was possible to substantially reduce… Read More